CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Mycenax Biotech Incorporated Company Snapshot
Mycenax Biotech Incorporated operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mycenax Biotech Incorporated with three other companies in this sector in Taiwan: Abnova (Taiwan) Corporation (2017 sales of 475.07 million Taiwanese Dollars [US$15.28 million] of which 100% was Antibody), EirGenix Inc (297.87 million Taiwanese Dollars [US$9.58 million] ), and Genmont Biotech Inc (552.94 million Taiwanese Dollars [US$17.78 million] of which 69% was Jingyue Company).

Sales Analysis. Mycenax Biotech Incorporated reported sales of 318.64 million Taiwanese Dollars (US$10.25 million) for the year ending December of 2017. This represents an increase of 58.8% versus 2016, when the company's sales were 200.61 million Taiwanese Dollars. Sales at Mycenax Biotech Incorporated have increased during each of the previous five years (and since 2012, sales have increased a total of 793%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Mycenax Biotech Incorporated
  Stock Performance Chart for Mycenax Biotech Incorporated
 
  Stock Data: Recent Stock Performance:
  Current Price (10/12/2018): 21.60
(Figures in Taiwanese Dollars)
1 Week -20.4%   13 Weeks -4.0%  
4 Weeks -4.6%   52 Weeks -23.3%  
 
Mycenax Biotech Incorporated Key Data:
  Ticker: 4726 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 318,637,000
(Year Ending Jan 2018).
Employees: 63
  Currency: Taiwanese Dollars Market Cap: 2,375,028,000
  Fiscal Yr Ends: December Shares Outstanding: 109,955,000
  Share Type: GU Closely Held Shares: N/A
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.